CURX
Curanex Pharmaceuticals Inc
NASDAQ · Healthcare · Biotechnology · US
$4.40
−4.35%Institutional positioning
13F filings over the trailing two quarters
New 8Increased 4Reduced 7Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 111,130 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 95,258 | Sep 2, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 56,651 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 52,000 | Aug 13, 2026 |
| XTX TOPCO LTD | Increased | 51,289 | May 15, 2026 |
| Virtu Financial LLC | New Position | 51,236 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | Reduced | 50,559 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 38,288 | Aug 12, 2026 |
| JANE STREET GROUP, LLC | New Position | 31,215 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 27,354 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 20,254 | May 15, 2026 |
| CITIGROUP INC | New Position | 19,332 | May 11, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 14,657 | Aug 14, 2026 |
| Ground Swell Capital, LLC | New Position | 12,638 | Aug 5, 2026 |
| JUMP FINANCIAL, LLC | Reduced | 10,551 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings